Retatrutides safety profile compares favourably to Semaglutide on almost every GI metric while delivering substantially better weight loss outcomes
This is one of many areas where ongoing peptide research and clinical studies continue to expand our understanding
In a healthy body, these mediators are released in measured doses to fight infections or heal wounds
(2016) found the most common comorbities in MCAS, occurring in over 10% of patients, were gastroesophageal reflux disease (GERD) 35% hypertension 29% multiple/atypical drug reactions 23% abdominal pain not otherwise specified 22% hysterectomy/oophorectomy 21% hyperlipidemia 20% cholecystectomy 20% environmental allergies 19% tobacco abuse 18% asthma 18% diabetes mellitus type 2 17% hypothyroidism 17% headaches 17% depression 16% sinusitis 16% fibromyalgia 16% anemia of chronic inflammation 15% sleep apnea 15% frequent upper respiratory tract infections 15% miscarriage 15% pharyngitis (sore throat caused by inflammation) or tonsillitis 14% dysmenorrhea 14% thromboembolism 13% frequent or atypical infections 13% obesity 13% osteoarthritis 13% anxiety/panic 12% vertebral disease 12% cardiovascular malformations 12% dermatitis 11 % presyncope or syncope 11 % interstitial cystitis 11 % chronic kidney disease 10% POTS 10% [4] MCAS is often diagnosed in patients that have been previously diagnosed with Ehlers-Danlos syndrome (EDS), a heritable connective tissue disorder, and with postural orthostatic tachycardia syndrome (POTS), a form of orthostatic intolerance
Feb 10, 2026 You have the vial
Support your daily health with Applied Nutrition Magnesium & Vitamin D3,
